Overview

Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This interventional study aims to evaluate the efficacy of Cyclosporine eye drop treatment in preventing relapses of Vernal Keratoconjunctivitis (VKC) and in treating the acute phases of the disease.
Phase:
Phase 3
Details
Lead Sponsor:
Campus Bio-Medico University
Collaborators:
University of Genova
University of Padova
Treatments:
Cyclosporine
Cyclosporins
Ketotifen
Ophthalmic Solutions
Tetrahydrozoline